Once again the Burgos are turned with a solidarity cause.Last Saturday the Association of Diabetics of Burgos (Adisbur) raised 4,762 euros in favor of the Diabetes Zero Foundation in a beneficial magic gala for which "all the available entrances were sold", as noted by the president of the association,Cristina Llorente.

The collection is destined to research in a cure for the disease and it is that Diabetes Zero Foundation is a movement of parents of children with diabetes and adults whose objective is the monitoring and financing of a real and lasting investigation."They know the State and the advance of research and that is why we think it was the best destination for collection," explains Llorente and ensures that "the Foundation believes in scientists, they are the ones who investigate so that society has a better qualityof life and that is why in his annual congress he gives scholarships to researchers ».

The president of the entity was surprised and grateful for the participation of Burgos Society."It has been impressive because we did not expect to have such a good response from both the Burgos and the participating companies and artists, who have collaborated altruistically."

The final brooch of the gala were in charge of putting the children of the association itself who “wanted to launch a message of hope and fight with the motto,‘ I was not born to give myself.For a future without diabetes, "says the president, who remembers that" precisely last week we woke up with the news that researchers have developed the first drug with the potential to cure diabetes, successfully in transgenic mice. "

The association already has the mind set in its next activity."We are preparing a day on diabetes and nutrition in collaboration with the Umami Nutrition Center", which "will predictably take place the second half of May," says Llorente.

In Castilla y León there are more than 300,000 diabetic people, of which 15,000 are under 18.The World Health Organization warned in 2016 of the progressive increase in the number of affected by the disease, which is currently 1 in 11 people worldwide.